×÷Õߣº¶¡Õñ½ ÓàÖ¾ÖÐ Ðì¹úºé ÎâËëÁá ÎâÇì·æ ¹ù½õÌÏ ½¯½¡²ý ÁõËØ·¼
¡¾¹Ø¼ü´Ê¡¿ ,¾«Éñ·ÖÁÑÖ¢£»ÀûÅàͪ£»ÂȵªÆ½£»ÑªÌÇ
¡¡¡¡¡¾ÕªÒª¡¿ Ä¿µÄ ̽ÌÖÀûÅàͪ¶ÔÌÇ´úлµÄÓ°Ïì¡£ ·½·¨ ½«63Àý¾«Éñ·ÖÁÑÖ¢»¼ÕßËæ»ú·ÖΪÀûÅàͪ×é31ÀýºÍÂȵªÆ½×é32Àý£¬Á½×é¾ùµ¥Ò»ÓÃÒ©£¬ÀûÅàͪƽ¾ù¼ÁÁ¿4.0¡À0.74mg・d-1£¬ÂȵªÆ½Æ½¾ù¼ÁÁ¿340.56¡À122.43mg・d-1¡£ÐË·ÜÔ궯ºÍ˯ÃßÕϰÕß¿ÉÁªºÏС¼ÁÁ¿±½¶þµªÜ³[]׿ÀàÒ©Îï¡£ÁƳ̾ùΪ8w¡£·Ö±ðÓÚÖÎÁÆÇ°¼°ÖÎÁƵÚ4¡¢8wÄ©³¿³é¿Õ¸¹¾²ÂöѪ¼ì²âѪÌÇ£»ÖÎÁÆÇ°¼°ÖÎÁƵÚ8wÄ©²âÁ¿ÌåÖØ¡£ ½á¹û ÖÎÁƵÚ8wÄ©£¬ÂȵªÆ½×éѪÌÇÃ÷ÏÔ¸ßÓÚÀûÅàͪ×飬²îÒìÓм«ÏÔÖøÐÔ£¨P£¼0.01£©£»ÀûÅàͪ×黼ÕßµÄÄêÁäÓëÖÎÁÆ4wĩѪÌǺÍ8wÄ©ÌåÖØ´æÔÚÏà¹Ø¹ØÏµ£¨r=0.496£¬P=0.007£»r=0.493£¬P=0.006£©¡£ ½áÂÛ ÀûÅàͪÓëÂȵªÆ½¾ù¿ÉÒýÆðѪÌÇÉý¸ß£¬µ«ÂȵªÆ½¶ÔѪÌǵÄÓ°Ïì½ÏÀûÅàͪÏÔÖø¡£
¡¡¡¡Control studies of increase of blood sugar induced by neoantipsychotics
¡¡¡¡¡¾Abstract¡¿ Objective To explore the effects of risperidone on glycometabolism. Methods 63 schizophrenics were randomly divided into risperdone (n=31) and clozapine(n=32) group, the mean dosages of risperdone and clozapine were respectively 4.0¡À0.74mg/d and 340.56¡À122.43mg/d for 8 weeks. Patients with excitement or somnipathy could be given small dose of benzodiazepines. Fasting bloods in the early morning were taken to measure blood sugar before treatment and at the ends of 4th and 8th week, respectively.; body weight was measured before treatment and at the end of 8th week. Results At the end of 8th week, the blood sugar of clozapine group was significantly higher than that of risperdone group£¨P<0.01£©; the age of patients in risperdone group was related to blood sugar of 4th week and the body weight of 8th week£¨r=0.496,P=0.007£»r=0.493,P=0.006£©.Conclusion Both risperdal and clozapine could cause the rise of blood sugar, especially clozapine.
¡¡¡¡¡¾Keywords¡¿ Schizophrenia; risperdone; clozapine; blood sugar
¡¡¡¡ÐÂÐÍ¿¹¾«Éñ²¡Ò©ÎïÔÚ¸ÄÉÆ»¼Õß¾«ÉñÖ¢×´£¬Ìá¸ß»¼ÕßÉú»îÖÊÁ¿·½Ãæ·¢»ÓÁËÖØÒª×÷Óᣵ«Ò²·¢ÏÖ£¬²¿·Ö»¼ÕßÓ¦ÓøÃÀàÒ©ÎïÖÎÁƺó³öÏÖ²»Í¬³Ì¶ÈµÄÌåÖØÔö¼ÓºÍ/»ò·ÊÅÖ£¬ÑªÌÇÉý¸ß»òÆÏÌÑÌÇÄÍÁ¿Òì³£ÒÔ¼°¸ß֬Ѫ֢µÈ²»Á¼·´Ó¦£Û1¡«3£Ý£¬´ó´ó½µµÍÁË»¼ÕßÖÎÁƵÄÒÀ´ÓÐÔ¡£Îª´Ë£¬ÎÒÃÇÑ¡ÓÃÀûÅàͪºÍÂȵªÆ½½øÐÐÁ˶ÔÕÕÑо¿£¬ÒÔ̽ÌÖÁ½Ò©¶Ô¾«Éñ·ÖÁÑÖ¢»¼ÕßѪÌǵÄÓ°Ï죬ÏÖ±¨¸æÈçÏ¡£
¡¡¡¡1 ×ÊÁÏÓë·½·¨
¡¡¡¡1.1¶ÔÏó ѡȡ2004Äê1¡«12ÔÂÎÒԺסԺµÄ63Àý¾«Éñ·ÖÁÑÖ¢»¼ÕßΪÑо¿¶ÔÏó¡£¾ù·ûºÏ¡¶Öйú¾«ÉñÕϰ·ÖÀàÓëÕï¶Ï±ê×¼¡·µÚ3°æ£¨CCMD3£©¾«Éñ·ÖÁÑÖ¢Õï¶Ï±ê×¼£»¾»¼Õß¼°¼ÒÊôÖªÇéͬÒ⣻ÅųýÑÏÖØÇûÌå¼²²¡¡¢ÄÔÆ÷ÖÊÐÔ¼²²¡¡¢Ò©ÎïÀÄÓá¢ÈÑÉï¡¢²¸È鸾Ů¼°Ò©Îï¹ýÃôÕß¡£Ëæ»ú½«Èë×é¶ÔÏó·ÖΪÀûÅàͪ×é31ÀýºÍÂȵªÆ½×é32Àý¡£ÀûÅàͪ×éÄÐ19Àý£¬Å®12Àý£¬Æ½¾ùÄêÁä30.77¡À12.11a£¬Æ½¾ù²¡³Ì25.53¡À29.34mo£»ÂȵªÆ½×éÄÐ15Àý£¬Å®17Àý£¬Æ½¾ùÄêÁä31.19¡À11.33a£¬Æ½¾ù²¡³Ì71.36¡À105.12mo¡£Á½×éÄêÁä¡¢ÐԱ𡢲¡³ÌµÈ·½Ãæ¾ùÎÞÏÔÖøÐÔ²îÒ죨P£¾0.05£©¡£
¡¡¡¡1.2 ·½·¨ Á½×é¾ùµ¥Ò»ÓÃÒ©£¬ÀûÅàͪƽ¾ù¼ÁÁ¿4.0¡À0.74mg・d-1£¬ÂȵªÆ½Æ½¾ù¼ÁÁ¿340.56¡À122.43mg・d-1¡£ÐË·ÜÔ궯ºÍ˯ÃßÕϰÕß¿ÉÁªºÏС¼ÁÁ¿±½¶þµªÜ³[]׿ÀàÒ©Îï¡£ÁƳ̾ùΪ8w¡£·Ö±ðÓÚÖÎÁÆÇ°¼°ÖÎÁƵÚ4¡¢8wÄ©³¿³é¿Õ¸¹¾²ÂöѪ5ml¼ì²âѪÌÇ£¨²ÉÓÃÆÏÌÑÌÇÑõ»¯Ã¸·¨ÔÚÈÕÁ¢7060È«×Ô¶¯Éú»¯·ÖÎöÒÇÉÏÍê³É£©£»ÖÎÁÆÇ°¼°ÖÎÁƵÚ8wÄ©²âÁ¿ÌåÖØ¡£ËùÓÐÊý¾Ý²ÉÓÃSPSS10.0Èí¼þ°üͳ¼Æ´¦Àí£¬²¢½øÐÐt¼ìÑé¼°pearsonÏà¹Ø·ÖÎö¡£